AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home hLife Article
Article Link
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Letter | Open Access

Rational design of human CD26 receptor for a strong neutralizing ability against MjHKU4r-CoV-1 and MERS-CoV

Yalei Zhang1,2,#, Mingxiong Tian1,#, Yanjun Han1,2,#, Junqing Sun3,4, Wenwei Li5, Chongzhi Bai6( ), Chao Su1( ), Pengcheng Han1( )
Jiangsu Provincial Key Laboratory of Critical Care Medicine, School of Medicine, Zhongda Hospital, Advanced Institute for Life and Health, Southeast University, Jiangsu, China
College of Veterinary Medicine, Shanxi Agricultural University, Shanxi, China
Innovative Vaccine and Immunotherapy Research Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China
State Key Laboratory of Transvascular Implantation Devices, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China
Shanxi Academy of Advanced Research and Innovation, Shanxi, China
Central Laboratory, Shanxi Province Hospital of Traditional Chinese Medicine, Shanxi, China

#These authors contributed equally to this work

Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
hLife
Volume 3 Issue 11,
November 2025
Pages 565-568
DOI: 10.1016/j.hlife.2025.05.005

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Zhang Y, Tian M, Han Y, et al. Rational design of human CD26 receptor for a strong neutralizing ability against MjHKU4r-CoV-1 and MERS-CoV. hLife, 2025, 3(11): 565-568. https://doi.org/10.1016/j.hlife.2025.05.005

421

Views

0

Crossref
Received: 01 April 2025
Revised: 30 April 2025
Accepted: 16 May 2025
Published: 01 November 2025
© 2025 The Author(s).

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).